Bumper Offer - Urjas oil Just @ Rs. 1
Duolin Rotacap (30) is a prescription medicine that is available as a Rotacaps. Secondary and off-label uses of Duolin Rotacap (30) have also been mentioned below.
The optimal dosage of Duolin Rotacap (30) is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Duolin Rotacap (30) can also lead to other problems, which have been listed below. These side effects of Duolin Rotacap (30) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Duolin Rotacap (30)'s effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Duolin Rotacap (30)'s effects on the liver, heart and kidney, if any, have been listed below.
Some other conditions that can be affected by Duolin Rotacap (30) are listed in the contraindications section below.
Besides this, Duolin Rotacap (30) may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Duolin Rotacap (30) is not safe while driving, and is not addiction.
Duolin Rotacap (30) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Duolin Rotacap (30) is used -
Moderate
Mild
Is the use of Duolin Rotacap (30) safe for pregnant women?
Duolin can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Duolin right away. Take your doctor's advice before taking it again.
Is the use of Duolin Rotacap (30) safe during breastfeeding?
Duolin may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Duolin, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Duolin.
What is the effect of Duolin Rotacap (30) on the Kidneys?
Duolin has very mild side effects on the kidneys.
What is the effect of Duolin Rotacap (30) on the Liver?
Very few cases of side effects of Duolin on the liver have been reported.
What is the effect of Duolin Rotacap (30) on the Heart?
There may be an adverse effect on the heart after taking Duolin. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Duolin Rotacap (30) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Duolin Rotacap (30) unless your doctor advises you to do so -
Is this Duolin Rotacap (30) habit forming or addictive?
Duolin Rotacap (30) is not addictive in nature.
Interaction between Food and Duolin Rotacap (30)
There isn't any research available on the side effects of taking Duolin Rotacap (30) with food.
Interaction between Alcohol and Duolin Rotacap (30)
No research has been done on this till date. Therefore, it is not known what the effect of taking Duolin Rotacap (30) with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 705
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 116
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Atrovent® HFA (ipratropium bromide HFA)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ipravent® (ipratropium bromide)